Evaluation of the hypoglycemic, hypolipidemic and hepatic glycogen raising effects of Syzygium malaccense upon streptozotocin induced diabetic rats

K. L. Bairy, A. Sharma, Adiga Shalini

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Objective: To study the effect of Syzygium malaccense on serum glucose, lipid profile and liver glycogen content in both normal and hyperglycemic rats. Methods: The aqueous and alcoholic extracts were compared with glibenclamide for their influence on fasting blood sugar, lipid profile and liver glycogen in both normoglycemic and to streptozotocin induced (50mg/kg ip) hyperglycemic rats. Results: In normoglycemic rats the aqueous and alcoholic extracts produced hypoglycemia but did not affect the lipid profile and liver glycogen content even on chronic treatment. In the hyperglycemic rats on chronic treatment both the extracts caused reduction in FBS and significantly reversed the diabetes induced hyperlipidemia and liver glycogen depletion. The alcoholic extract was found to be more active than aqueous and equivalent to that of glibenclamide. Conclusion: The extracts of Syzygium malaccense with their beneficial effects on blood sugar and hyperlipidemia associated with diabetes could serve as good adjuvant to other oral hypoglycemic agents.

Original languageEnglish
Pages (from-to)46-51
Number of pages6
JournalJournal of Natural Remedies
Volume5
Issue number1
Publication statusPublished - 01-01-2005

Fingerprint

Syzygium
Liver Glycogen
Streptozocin
Hypoglycemic Agents
Glyburide
Hyperlipidemias
Lipids
Blood Glucose
Hypoglycemia
Fasting
Glucose
Serum

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this

@article{2e0e0ba537844c6d85e1a04daad71b6e,
title = "Evaluation of the hypoglycemic, hypolipidemic and hepatic glycogen raising effects of Syzygium malaccense upon streptozotocin induced diabetic rats",
abstract = "Objective: To study the effect of Syzygium malaccense on serum glucose, lipid profile and liver glycogen content in both normal and hyperglycemic rats. Methods: The aqueous and alcoholic extracts were compared with glibenclamide for their influence on fasting blood sugar, lipid profile and liver glycogen in both normoglycemic and to streptozotocin induced (50mg/kg ip) hyperglycemic rats. Results: In normoglycemic rats the aqueous and alcoholic extracts produced hypoglycemia but did not affect the lipid profile and liver glycogen content even on chronic treatment. In the hyperglycemic rats on chronic treatment both the extracts caused reduction in FBS and significantly reversed the diabetes induced hyperlipidemia and liver glycogen depletion. The alcoholic extract was found to be more active than aqueous and equivalent to that of glibenclamide. Conclusion: The extracts of Syzygium malaccense with their beneficial effects on blood sugar and hyperlipidemia associated with diabetes could serve as good adjuvant to other oral hypoglycemic agents.",
author = "Bairy, {K. L.} and A. Sharma and Adiga Shalini",
year = "2005",
month = "1",
day = "1",
language = "English",
volume = "5",
pages = "46--51",
journal = "Journal of Natural Remedies",
issn = "0972-5547",
publisher = "Natural Remedies Private Limited",
number = "1",

}

TY - JOUR

T1 - Evaluation of the hypoglycemic, hypolipidemic and hepatic glycogen raising effects of Syzygium malaccense upon streptozotocin induced diabetic rats

AU - Bairy, K. L.

AU - Sharma, A.

AU - Shalini, Adiga

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Objective: To study the effect of Syzygium malaccense on serum glucose, lipid profile and liver glycogen content in both normal and hyperglycemic rats. Methods: The aqueous and alcoholic extracts were compared with glibenclamide for their influence on fasting blood sugar, lipid profile and liver glycogen in both normoglycemic and to streptozotocin induced (50mg/kg ip) hyperglycemic rats. Results: In normoglycemic rats the aqueous and alcoholic extracts produced hypoglycemia but did not affect the lipid profile and liver glycogen content even on chronic treatment. In the hyperglycemic rats on chronic treatment both the extracts caused reduction in FBS and significantly reversed the diabetes induced hyperlipidemia and liver glycogen depletion. The alcoholic extract was found to be more active than aqueous and equivalent to that of glibenclamide. Conclusion: The extracts of Syzygium malaccense with their beneficial effects on blood sugar and hyperlipidemia associated with diabetes could serve as good adjuvant to other oral hypoglycemic agents.

AB - Objective: To study the effect of Syzygium malaccense on serum glucose, lipid profile and liver glycogen content in both normal and hyperglycemic rats. Methods: The aqueous and alcoholic extracts were compared with glibenclamide for their influence on fasting blood sugar, lipid profile and liver glycogen in both normoglycemic and to streptozotocin induced (50mg/kg ip) hyperglycemic rats. Results: In normoglycemic rats the aqueous and alcoholic extracts produced hypoglycemia but did not affect the lipid profile and liver glycogen content even on chronic treatment. In the hyperglycemic rats on chronic treatment both the extracts caused reduction in FBS and significantly reversed the diabetes induced hyperlipidemia and liver glycogen depletion. The alcoholic extract was found to be more active than aqueous and equivalent to that of glibenclamide. Conclusion: The extracts of Syzygium malaccense with their beneficial effects on blood sugar and hyperlipidemia associated with diabetes could serve as good adjuvant to other oral hypoglycemic agents.

UR - http://www.scopus.com/inward/record.url?scp=14844357210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14844357210&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 46

EP - 51

JO - Journal of Natural Remedies

JF - Journal of Natural Remedies

SN - 0972-5547

IS - 1

ER -